您的位置: 首页 > 农业专利 > 详情页

SIRNA FOR INHIBITING C-MET EXPRESSION AND ANTI-CANCER COMPRISING THE SAME
专利权人:
SAMYANG BIOPHARMACEUTICALS CORPORATION
发明人:
KIM, SUN-OK,KIM, SANG-HEE,CHO, EUN-AH,IN, CHANG-HOON
申请号:
EP10841247
公开号:
EP2520651A4
申请日:
2010.12.28
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
Disclosed are small interfering RNA (siRNA) that complementarily binds to a base sequence of c-Met transcript (mRNA transcript), thereby inhibiting expression of c-Met without inducing immune responses, and use of the siRNA for prevention and/or treatment of cancer. The siRNA that complementarily binds to c-Met-encoding mRNA may inhibit expression of c-Met, which is commonly overexpressed in almost all cancer cells, through RNA interference (RNAi), thereby inhibiting proliferation and metastasis of cancer cells, and thus, the siRNA may be useful as an anticancer agent.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充